Dr. Katharina Beck
Katharina graduated 2013 in Pharmaceutical Sciences at the ETH Zurich and received a federal diploma as a pharmacist. For her Master thesis she joined the ETH group for Radiopharmaceutical Sciences. The main purpose of her thesis was the identification of possible targets for imaging exclusively vulnerable atherosclerotic plaques in humans. She started her PhD in April 2014 in Prof. Alex Odermatt’s laboratory investigating interferences of xenobiotics with nuclear hormone receptor function.
|Araya, Selene; Kratschmar, Denise V.; Tsachaki, Maria; Stücheli, Simon; Beck, Katharina R.; Odermatt, Alex: DHRS7 (SDR34C1) - A new player in the regulation of androgen receptor function by inactivation of 5α-dihydrotestosterone? in: Journal of Steroid Biochemistry and Molecular Biology 171, 2017, S. 288-295. edoc|
|Beck, Katharina R.; Bächler, Murielle; Vuorinen, Anna; Wagner, Sandra; Akram, Muhammad; Griesser, Ulrich; Temml, Veronika; Klusonova, Petra; Yamaguchi, Hideaki; Schuster, Daniela; Odermatt, Alex: Inhibition of 11β-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole, in: Biochemical pharmacology 130, 2017, S. 93-103. edoc|
|Beck, Katharina R.; Kaserer, Teresa; Schuster, Daniela; Odermatt, Alex: Virtual screening applications in short-chain dehydrogenase/reductase research, in: Journal of Steroid Biochemistry and Molecular Biology 171, 2017, S. 157-177. edoc|